Access90: Inflation Reduction Act Insights Series – Patient Affordability: A Key Question Answered
Will the Inflation Reduction Act actually increase drug affordability? Well…it’s complicated. RyanCox, VP, Director, PRECISIONvalue Access Experience Team, outlines the ways it will cut costs—and some watchouts. Learn more in this 90-second video.
Access90: Inflation Reduction Act Insights Series – Impacts on Competition A Key Question Answered
How do you compete against a negotiated drug? As the Inflation Reduction Act challenges current formulary dynamics, PRECISIONvalue expert Erin Lopata has a succinct answer: Prove your value. Learn more in this 90-second video.
Article: Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forward With Dr. Jason Mouabbi, Dr. Ross Maclean, and Michael Glover
Accelerated FDA approvals are under scrutiny and at the center of many debates. Explore the complexities, benefits, and risks of accelerated approvals with Ross Maclean, EVP at PRECISIONheor & Head of Medical Affairs at Precision Value & Health, in an insightful discussion alongside Dr. Jason A. Mouabbi, Breast Medical Oncologist at MD Anderson.
PRECISIONadvisors Recognized as a Vault Top Ranked Consulting Firm
PRECISIONadvisors has been recognized as a Vault Top Ranked Consulting Firm! This marks PRECISIONadvisors’ inaugural appearance on the prestigious Vault Consulting 50 list, which evaluates firms based on confidential employee input covering aspects such as workplace culture and quality of life.
The firm secured rankings in four distinct categories:
- Vault Consulting 50 North America
- Best Boutique Consulting Firms
- Best Consulting Firms for Women
- Best Consulting Firms for Formal Training
Access90: Inflation Reduction Act Insight Series – Payer Controls: Question Two: How Could Manufacturers Adapt Their Approach to Patient Access?
Higher premiums. Increased brand exclusions. Limited treatment populations. Payers may deploy an arsenal of defenses against rising drug costs—and manufacturers should adapt to support patient access. Dominic Galante, Chief Medical Officer PRECISIONvalue, shares thoughts on effective strategies in this short Access90 video.
Article: Tight-Knit Patient Communities Open Their Doors to Pharma
The rules of engagement for patient and caregiver communities have changed. Once off limit to industry insiders, patient communities are now opening their doors to pharma. What does this mean for pharma companies and how do you shift your strategy? Jack DeManche, Director of Digital Strategy at PRECISIONeffect, chats with MM+M and other industry leaders about the catalysts driving the shift towards greater community engagement, insights into the evolving landscape of patient involvement, and nuanced approaches to fostering collaborations.
Article: Navigating Health Equity in 2024: The Evolution of Accountability, Part 2
In Part 2, Maureen Hennessey, SVP, Director of Value Transformation, PRECISIONvalue with Elizabeth Oyekan, VP Pharmacy and Imaging Services, Stanford Health Care and Valerie Nguyen, dive deeper into Navigating Health Equity in 2024, focusing on the significance of accreditations in addressing health disparities and promoting health equity, highlighting programs for achieving accreditation and advocating for the integration of social determinants of health (SDOH) and health equity practices within pharmacy and health care.
Article: Doubling Down on Deep Customer Insights to Inform Value Demonstration
An expert view from Ross Maclean, Head of Medical Affairs and Jon Bambalas, SVP, Business Development, Precision Value & Health, on how insights from patient-level health insurance benefits data can serve the pharmaceutical industry – namely, how coverage insights can inform the generation of evidence to demonstrate to payers and providers the value of a specific treatment.
Register for a free trial subscription and read the article HERE!
Article: Navigating Health Equity in 2024: The Evolution of Accountability, Part 1
2024 will be the first full year in which health systems will be held accountable by The Joint Commission (TJC) for performance on their National Patient Safety Goal to improve health care equity. Marueen Hennessey, SVP, Director of Value Transformation, PRECISIONvalue with Elizabeth Oyekan, VP Pharmacy and Imaging Services, Stanford Health Care and Valerie Nguyen, Healthcare Administration Graduate Intern at Stanford Health Care share their unique perspectives in this AJMC article.
Access90: Inflation Reduction Act Insight Series – Payer Controls: Two Key Questions Answered
Patients already look beyond their prescription benefits for ways to pay. As cost-sharing rises and payer formulary controls and exclusions expand, patient demand for new solutions will grow. PRECISIONvalue Chief Medical Officer Dominic Galante discusses the future of access management in this Access90 video.